Abstract
Reports of hematopoietic stem-cell transplantation (HSCT) following solid-organ transplantation have been described in adults mainly as case reports. These reports demonstrate feasibility but likely do not reflect true outcomes due to a positive reporting bias. We report herein the outcomes of all our pediatric recipients of allogeneic HSCT following previous solid-organ transplantation between 2000 and 2009. Four children were identified. Two patients underwent heart transplantation followed by cord-blood allogeneic HSCT for T-cell lymphoma/post transplant lymphoproliferative disease (PTLD) and two patients underwent liver transplantation followed by living-donor allogeneic HSCT for severe aplastic anemia (SAA). The mean time between transplants was 4.2 years (range 1.5–6 years). All patients engrafted; however, all patients died from 37 days to 1 year after HSCT. Causes of death included infections (n=2), multi-organ failure (n=1) and solid-organ graft rejection (n=1). Though three patients survived beyond day+100, multiple complications were observed including EBV re-activation followed by EBV-positive PTLD (n=1) and five episodes of severe infections. The patients transplanted for lymphoma did not have evidence of recurrence at last follow-up. Although feasibilty has been shown with this cohort, we conclude that allogeneic HSCT in immunosuppressed patients following solid-organ transplantation remains a very high risk procedure that results in severe morbidity and mortality in children.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Mangat JS, Rao K, Kingston J, Veys P, Amrolia P, Burch M . Early pediatric antracycline cardiotoxicity: managed be serial heart and bone marrow transplantation. J Heart Lung Transplant 2007; 26: 658–660.
Kawahara K, Storb R, Sanders J, Petersen FB . Successful allogeneic bone marrow transplantation in a 6.5-year-old male for severe aplastic anemia complicating orthotopic liver transplantation for fulminant non-A-non-B hepatitis. Blood 1991; 78: 1140–1143.
Hagglund H, Winiarski J, Ringden O, Sparrelid E, Ericzon BG . Successful allogeneic bone marrow transplantation in a 2.5-year-old boy with ongoing cytomegalovirus viremia and severe aplastic anemia after orthotopic liver transplantation for non-A, non-B, non-C hepatitis. Transplant 1997; 64: 1207–1208.
Trede NS, Warwick AB, Rosoff PM, Rohrer R, Bierer BE, Guinan E . Tacrolimus (FK506) in allogeneic bone marrow transplantation for severe aplastic anemia following orthotopic liver transplantation. Bone Marrow Transplant 1997; 20: 257–260.
Perkins JL, Neglia JP, Ramsay NKC, Davies SM . Successful bone marrow transplantation for severe aplastic anemia following orthotopic liver transplantation: long-term follow-up and outcome. Bone Marrow Transplant 2001; 28: 523–526.
Yoshimi A, Nnny Y, Ueda K, Asano D, Yamamoto G, Kumano K . successful hematopoietic stem cell transplantation from an HLA-identical sibling in a patient with aplastic anemia and HLA-haploidentical living-related liver transplantation for fulminant hepatitis. Biol Blood Marrow Transplant 2009; 15: 389–390.
Manlhiot C, Pollock-Barziv SM, Holmes S, Weitzman S, Allen U, Clarizia NA et al. Post transplant lymphoproliferative disorders in pediatric heart transplant patients. J Heart Lung Transplant 2010; 29: 648–657.
Jaffe ES, Harris NL, Stein H, Vardiman JW (eds). Immunodeficiency associated lymphoproliferative disorders. In: Tumours of Haematopoietic and Lymphoid Tissues. World Health Organization Classification of Tumours. IARC Press: Lyon, 2001.
Langer RM, Jaray J, Toth A, Hídvégi M, Végsö G, Perner F et al. De novo tumors after kidney transplantation: the Budapest experience. Transplant Proc 2003; 35: 1396–1398.
Penn I . Cancers in renal transplant recipients. Adv Ren Replace Ther 2000; 7: 147–156-.
Dharnidharka VE, Tejani AH, Ho PL . Posttransplant lymphoproliferative disorder in the United States: young Caucasian males are at higher risk. Am J Transplant 2002; 2: 993–998.
Herzig KA, Juffs HG, Norris D, Brown AM, Gill D, Hawley CM et al. A single-center experience of post-renal transplant lymphoproliferative disorder. Transplant Int 2003; 16: 529–536.
Webber SA, Naftel DC, Fricker FJ, Olesnevich P, Blume ED, Addonizio L et al. Pediatric Heart Transplant Study. Lymphoproliferative disorders after paediatric heart transplantation: a multi-institutional study. Lancet 2006; 367: 233–239.
Yousem SA, Randhawa P, Locker J, Paradis IL, Dauber JA, Griffith BP et al. Posttransplant lymphoproliferative disorders in heart-lung transplant recipients: primary presentation in the allograft. Hum Pathol 1989; 20: 361–369.
Nalesnik MA . Clinicopathologic features of posttransplant lymphoproliferative disorders. Ann Transplant 1997; 4: 33–40.
Bacigalupo A, Ballen K, Rizzo D, Giralt S, Lazarus H, Ho V et al. Defining the intensity of conditioning regimens: working definition. Biol Blood Marrow Transplant 2009; 15: 1628–1633.
Chiang KY, Lazarous HM . Should we be performing more combined hematopoietic stem cell plus solid organ transplants? Bone Marrow Transplant 2003; 31: 633–642.
Kobbe G, Germing U, Aivado M, Zohren F, Schubert D, Strupp C et al. Treatment of secondary myelodysplastic syndrome after heart transplantation with chemotherapy and nonmyeloablative stem-cell transplantation. Transplantation 2002; 74: 1198–1200.
Haldas J, Wang W, Lazarchick J . Post-transplant lymphoproliferative disorders: T-cell lymphoma following cardiac transplant. Leukemia Lymphoma 2002; 43: 447–450.
Draoua HY, Tsao L, Mancini DM, Addonizio LJ, Bhagat G, Alobeid B . T-cell post-transplantation lymphoproliferative disorders after cardiac transplantation: a single institutional experience. Br J Haematol 2004; 127: 429–432.
Rajakariar R, Bhattacharyya M, Norton A, Sheaff M, Cavenagh J, Raftery MJ et al. Post-transplant T-cell lymphoma: a case series of four patients from a single unit and review of the literature. Am J Transplant 2004; 4: 1534–1538.
Lundell R, Elenitoba-Johnson KS, Lim MS . T-cell post-transplant lymphoproliferative disorder occurring in a pediatric solid-organ transplant patient. Am J Surg Pathol 2004; 28: 967–973.
Williams KM, Higman MA, Chen AR, Schwartz CL, Wharam M, Colombani P et al. Successful treatment of a child with late onset T-cell post transplant lymphoproliferative disorder/lymphoma. Pediatr Blood Cancer 2008; 50: 667–670.
Feyler S, Prince HM, Pearce R, Towlson K, Nivison-Smith I, Schey S et al. The role of high-dose therapy and stem cell rescue in the management of T-cell malignant lymphomas: a BSBMT and ABMTRR study. Bone Marrow Transplant 2007; 40: 443–450.
Dai QY, Souillet G, Bertrand Y, Galambrun C, Bleyzac N, Manel AM et al. Antileukemic and long-term effects of two regimens with or without TBI in allogeneic bone marrow transplantation for childhood lymphoblastic leukemia. Bone Marrow Transplant 2004; 34: 667–673.
Thaunat O, Alyanakian MA, Varnous S, Bors V, Damaj G, Rerolle JP et al. Long-term successful outcome of sequential cardiac and allogeneic bone marrow transplantations in severe AL amyloidosis. Bone Marrow Transplant 2005; 35: 419–420.
Tzakis AG, Arditi M, Whitington PF, Yanaga K, Esquivel C, Andrews WA et al. Aplastic anemia complicating orthotopic liver transplantation for non-A, non-B hepatitis. New Engl J Med 1988; 319: 393–396.
Cattral MS, Langnas AN, Markin RS, Antonson DL, Heffron TG, Fox IJ et al. Aplastic anemia after liver transplantation for fulminant liver failure. Hepatology 1994; 20: 813–818.
Dey B, Sykes M, Spitzer TR . Outcomes of recipients of both bone marrow and solid organ transplants. A review. Medicine (Baltimore) 1998; 77: 355–369.
Hadzic N, Height S, Ball S, Rela M, Heaton ND, Veys P . Evolution in the management of acute liver failure-associated aplastic anaemia in children: a single centre experience. J Hepatol 2008; 48: 68–73.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Rights and permissions
About this article
Cite this article
Schechter-Finkelstein, T., Gassas, A., Weitzman, S. et al. Hematopoietic stem-cell transplantation following solid-organ transplantation in children. Bone Marrow Transplant 46, 1321–1325 (2011). https://doi.org/10.1038/bmt.2011.153
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/bmt.2011.153
Keywords
This article is cited by
-
Hemophagocytic lymphohistiocytosis presenting in a pediatric patient with near total colonic and small bowel aganglionosis: a case report
Journal of Medical Case Reports (2017)
-
Tolerance to liver allograft after allogeneic hematopoietic cell transplantation for severe aplastic anemia from the same HLA-matched sibling donor
Bone Marrow Transplantation (2012)